News & Analysis on Clinical Trial Services & Contract Research And Development
US-based drug delivery firm, BioDelivery Sciences International (BDSI), has asked for approval to start clinical trials of a soya bean-based delivery technology that would lead to the first oral version of amphotericin B, a widely-used antifungal drug.
This year is shaping up to be another good year for third party logistics (3PL) services firms focused on the pharmaceutical industry, according to Sentry.
US-based Averion has signed a deal with an Indian contract research organisation (CRO) to offer combined services to pharma and biotech companies.
Contract manufacturer Lonza has completed its acquisition of two Cambrex subsidiaries, research bioproducts and microbial biopharmaceutical, in a move that is fuelled by its strategic move into biopharmaceuticals.
Roche is the latest large pharma company to restructure its research and development into smaller disease-specific divisions to help get drugs on the market faster.
Cardinal Health has reached an agreement with the US Food and Drug Administration (FDA) on plans to resume manufacture and sale of its Alaris (SE) line of infusion pumps. Units were seized and production halted following grave safety concerns...
Wyeth Pharmaceuticals is expanding its research into small molecules schizophrenia drugs and biopharmaceuticals to treat haemophilia, having announced three deals in a day earlier this week.
UK-based firm BioProgress has developed novel tablet cores that mean pills which were previously very difficult to coat can be reformulated and easily coated using the company's innovative TabWrap technology.
AstraZeneca has continued to rapidly refocus and bolster its biologics pipeline through collaboration deals, this time with a deal for antibody producing technology.
Swedish packaging manufacturer Cerbo has developed a novel closure for tablet bottles as a user-friendly alternative for those who have limited dexterity in their hands and fingers.
ICON Clinical Research has teamed up with Phase Forward while etrials has scored 10 new contracts in the latest stage of the eclinical movement.
Laureate Pharma will now offer extra bioprocessing services to its customers following a new partnership deal signed with Boehringer Ingelheim.
In this week's review of activity within the preclinical research services arena, new deals have emerged involving Immunicon, Novartis, Southern Research Institute and Absorption Systems.